Roth Capital Starts Global Blood Therapeutics (GBT) at Buy, PT $47
Tweet Send to a Friend
Roth Capital initiated coverage on Global Blood Therapeutics (NASDAQ: GBT) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
